Could a simple food supplement tame ulcerative colitis?

NCT ID NCT07619638

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a once-daily food supplement designed to improve gut bacteria in people with mild-to-moderate ulcerative colitis. About 162 adults will take either the supplement or a placebo for 24 weeks, alongside their usual treatment. The goal is to see if the supplement helps achieve remission, meaning no bleeding, better stool frequency, and lower inflammation markers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
microbiome-targeted food supplement
What this could lead to
If it works, this could offer a simple, food-based option to help control ulcerative colitis symptoms and reduce gut inflammation.
What could go wrong
This is an early phase 2b trial with only 162 participants, so results may not apply to everyone. The supplement is not a cure and is meant to be used alongside standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ege University

    RECRUITING

    Izmir, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.